Literature DB >> 26604186

Practical guide to sample size calculations: non-inferiority and equivalence trials.

Laura Flight1, Steven A Julious1.   

Abstract

A sample size justification is a vital part of any trial design. However, estimating the number of participants required to give a meaningful result is not always straightforward. A number of components are required to facilitate a suitable sample size calculation. In this paper, the steps for conducting sample size calculations for non-inferiority and equivalence trials are summarised. Practical advice and examples are provided that illustrate how to carry out the calculations by hand and using the app SampSize.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  clinical trials; equivalence; non-inferiority; power; sample size

Mesh:

Year:  2015        PMID: 26604186     DOI: 10.1002/pst.1716

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  16 in total

Review 1.  Non-inferiority statistics and equivalence studies.

Authors:  J Walker
Journal:  BJA Educ       Date:  2019-04-24

2.  Effect of reactive balance training on physical fitness poststroke: study protocol for a randomised non-inferiority trial.

Authors:  Azadeh Barzideh; Susan Marzolini; Cynthia Danells; David Jagroop; Andrew H Huntley; Elizabeth L Inness; Sunita Mathur; George Mochizuki; Paul Oh; Avril Mansfield
Journal:  BMJ Open       Date:  2020-06-30       Impact factor: 2.692

3.  Efficacy of an internet-based exposure treatment for flying phobia (NO-FEAR Airlines) with and without therapist guidance: a randomized controlled trial.

Authors:  Daniel Campos; Juana Bretón-López; Cristina Botella; Adriana Mira; Diana Castilla; Sonia Mor; Rosa Baños; Soledad Quero
Journal:  BMC Psychiatry       Date:  2019-03-06       Impact factor: 3.630

4.  Comparing azathioprine with cyclosporine in the treatment of antihistamine refractory chronic spontaneous urticaria: A randomized prospective active-controlled non-inferiority study.

Authors:  Yashdeep Singh Pathania; Anuradha Bishnoi; Davinder Parsad; Ashok Kumar; Muthu Sendhil Kumaran
Journal:  World Allergy Organ J       Date:  2019-05-10       Impact factor: 4.084

5.  Study on efficacy and safety of Tong-luo Qu-tong plaster treatment for knee osteoarthritis: study protocol for a randomized, double-blind, parallel positive controlled, multi-center clinical trial.

Authors:  Bao-Ping Xu; Min Yao; Zi-Rui Tian; Long-Yun Zhou; Long Yang; Zhen-Jun Li; Sen Zhu; Xiao-Tao Wang; Jia-Hui Lan; Yong-Jun Wang; Xue-Jun Cui
Journal:  Trials       Date:  2019-06-24       Impact factor: 2.279

6.  Clinical study on acupuncture treatment of hypertension with hyperactivity of liver yang.

Authors:  Jiaojuan Wu; Xudong Zhang; Jiping Zhao; Yanjun Xue; Pengcheng Yu; Xiaoli Wu; Qingguo Liu
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

7.  A non-inferiority study evaluating a new extended-release preparation of tilmicosin injected subcutaneously vs. ceftiofur administered intramammary, as dry-cow therapy in Holstein Friesian cows.

Authors:  Esteban Ortega; Edgar Alfonseca-Silva; Eduardo Posadas; Graciela Tapia; Hector Sumano
Journal:  J Vet Sci       Date:  2020-11       Impact factor: 1.672

8.  Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the "Stratall ANRS 12110 / ESTHER" trial.

Authors:  Arsene Brunelle Sandie; Nicolas Molinari; Anthony Wanjoya; Charles Kouanfack; Christian Laurent; Jules Brice Tchatchueng-Mbougua
Journal:  Trials       Date:  2022-03-05       Impact factor: 2.279

9.  Lengthening adalimumab dosing interval in quiescent Crohn's disease patients: protocol for the pragmatic randomised non-inferiority LADI study.

Authors:  L J T Smits; R W M Pauwels; W Kievit; D J de Jong; A C de Vries; F Hoentjen; C J van der Woude
Journal:  BMJ Open       Date:  2020-05-26       Impact factor: 2.692

10.  A brief intervention for PTSD versus treatment as usual: Study protocol for a non-inferiority randomized controlled trial.

Authors:  Halvor Stavland; Camilla Refvik; Jarle Eid; Rafiq Lockhat; Åsa Hammar
Journal:  Trials       Date:  2021-10-25       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.